120 related articles for article (PubMed ID: 7680062)
1. Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child.
McFarland EJ; Curiel TJ; Schoen DJ; Rosandich ME; Schooley RT; Kuritzkes DR
J Infect Dis; 1993 Mar; 167(3):719-23. PubMed ID: 7680062
[TBL] [Abstract][Full Text] [Related]
2. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
McFarland EJ; Harding PA; Luckey D; Conway B; Young RK; Kuritzkes DR
J Infect Dis; 1994 Oct; 170(4):766-74. PubMed ID: 7930716
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
Carmichael A; Jin X; Sissons P; Borysiewicz L
J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
[TBL] [Abstract][Full Text] [Related]
4. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children.
Luzuriaga K; Koup RA; Pikora CA; Brettler DB; Sullivan JL
J Pediatr; 1991 Aug; 119(2):230-6. PubMed ID: 1907319
[TBL] [Abstract][Full Text] [Related]
5. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1.
Tsomides TJ; Aldovini A; Johnson RP; Walker BD; Young RA; Eisen HN
J Exp Med; 1994 Oct; 180(4):1283-93. PubMed ID: 7523570
[TBL] [Abstract][Full Text] [Related]
6. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
Koup RA; Pikora CA; Luzuriaga K; Brettler DB; Day ES; Mazzara GP; Sullivan JL
J Exp Med; 1991 Dec; 174(6):1593-600. PubMed ID: 1744586
[TBL] [Abstract][Full Text] [Related]
7. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
[TBL] [Abstract][Full Text] [Related]
8. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
Bernard NF; Pederson K; Chung F; Ouellet L; Wainberg MA; Tsoukas CM
AIDS; 1998 Nov; 12(16):2125-39. PubMed ID: 9833853
[TBL] [Abstract][Full Text] [Related]
9. CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual.
Curiel TJ; Wong JT; Gorczyca PF; Schooley RT; Walker BD
AIDS Res Hum Retroviruses; 1993 Jan; 9(1):61-8. PubMed ID: 7678973
[TBL] [Abstract][Full Text] [Related]
10. An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes.
Jin X; Ogg G; Bonhoeffer S; Safrit J; Vesanen M; Bauer D; Chen D; Cao Y; Demoitie MA; Zhang L; Markowitz M; Nixon D; McMichael A; Ho DD
Mol Med; 2000 Sep; 6(9):803-9. PubMed ID: 11071274
[TBL] [Abstract][Full Text] [Related]
11. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex.
Jassoy C; Johnson RP; Navia BA; Worth J; Walker BD
J Immunol; 1992 Nov; 149(9):3113-9. PubMed ID: 1383338
[TBL] [Abstract][Full Text] [Related]
12. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
Klein MR; van der Burg SH; Hovenkamp E; Holwerda AM; Drijfhout JW; Melief CJ; Miedema F
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
[TBL] [Abstract][Full Text] [Related]
13. An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag.
Littaua RA; Oldstone MB; Takeda A; Debouck C; Wong JT; Tuazon CU; Moss B; Kievits F; Ennis FA
J Virol; 1991 Aug; 65(8):4051-6. PubMed ID: 1712857
[TBL] [Abstract][Full Text] [Related]
14. Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells.
Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM
Immunol Lett; 1998 Dec; 64(2-3):71-7. PubMed ID: 9870657
[TBL] [Abstract][Full Text] [Related]
15. Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.
van Baalen CA; Klein MR; Geretti AM; Keet RI; Miedema F; van Els CA; Osterhaus AD
AIDS; 1993 Jun; 7(6):781-6. PubMed ID: 7689847
[TBL] [Abstract][Full Text] [Related]
16. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
Kundu SK; Merigan TC
AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
Beatty JA; Willett BJ; Gault EA; Jarrett O
J Virol; 1996 Sep; 70(9):6199-206. PubMed ID: 8709246
[TBL] [Abstract][Full Text] [Related]
18. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
[TBL] [Abstract][Full Text] [Related]
19. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
Ferrari G; King K; Rathbun K; Place CA; Packard MV; Bartlett JA; Bolognesi DP; Weinhold KJ
Clin Exp Immunol; 1995 Aug; 101(2):239-48. PubMed ID: 7544247
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins.
McGuire TC; Tumas DB; Byrne KM; Hines MT; Leib SR; Brassfield AL; O'Rourke KI; Perryman LE
J Virol; 1994 Mar; 68(3):1459-67. PubMed ID: 8107209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
